KEBIJAKAN KRIMINAL DALAM PENANGGULANGAN GRATIFIKASI DALAM HUBUNGAN DOKTER DAN PERUSAHAAN FARMASI

ANGGARA, WELLY and Achmad, Ruben and Ibrahim, Zulkarnain (2019) KEBIJAKAN KRIMINAL DALAM PENANGGULANGAN GRATIFIKASI DALAM HUBUNGAN DOKTER DAN PERUSAHAAN FARMASI. Undergraduate thesis, Sriwijaya University.

[img] Text
RAMA_74201_02012681418051_0002095502_01_front_ref.pdf - Accepted Version
Available under License Creative Commons Public Domain Dedication.

Download (1MB)
[img] Text
RAMA_74201_02012681418051_0002095502_02.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (462kB) | Request a copy
[img] Text
RAMA_74201_02012681418051_0002095502_03.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (634kB) | Request a copy
[img] Text
RAMA_74201_02012681418051_0002095502_04.pdf - Accepted Version
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (124kB) | Request a copy
[img] Text
RAMA_74201_02012681418051_0002095502_05_ref.pdf - Bibliography
Restricted to Repository staff only
Available under License Creative Commons Public Domain Dedication.

Download (424kB) | Request a copy

Abstract

This thesis discusses criminal policy in gratification prevention in relation of Doctor and pharmaceutical company. This type of research is normative, using statute, conceptual, and case approach, with the type and source of research material from secondary data. Technique of collecting research material through literature study, analyzed qualitatively, with deductive deduction technique. The results of this research are, if civil servant doctor fulfills the elements of gratification according to Article 12B and Article 12C Law No. 20 of 2001 on Amendment to Law No. 31 of 1999 on the Criminal Act of Corruption, and Article 1 of Health Minister Regulation No. 14 Year 2014 on Gratification Control in the Ministry of Health Environment, then meet the criteria of corruption in the form of gratification that is considered as bribe. While private doctors can not be the subject to criminal sanctions based on the regulation. The criminal policies to tackle gratification in the relationship between doctor and pharmaceutical company is through penal and non penal efforts. Penal Efforts: criminal responsibility for civil servant doctor through the application of criminal sanction in Article 12B paragraph (1) letter c, that is life imprisonment or imprisonment for a minimum of 4 years and maximum of 20 years, and a fine of at least Rp. 200.000.000,- and at most Rp. 1,000,000,000,-. The criminal responsibility of pharmaceutical company is regulated in Article 62 Paragraph (1) of Law No. 8 of 1999 concerning Consumer Protection stating that the business actor (medical representative and owner of a pharmaceutical company) violates the provisions of Article 13 paragraph (2) shall be punished with a maximum imprisonment of 5 years or maximum fine of Rp. 2,000,000,000, -. Non penal efforts : sponsorship is transparent without conflicts of interest, through institutional or organizations of medical profession; fulfillment by state of health care guarantee; the government make budget to education and training allowance of medical profession; regulation of civil servant doctor outside of service in government hospital; private sector role; obligation to report on acceptance of gratuities; religious approach; ethical code approach; and supervision of the implementation of the code of ethics.

Item Type: Thesis (Undergraduate)
Uncontrolled Keywords: gratification, Doctor, pharmaceutical company.
Subjects: K Law > K Law (General)
K Law > KD England and Wales
K Law > KF United States Federal Law
K Law > KZ Law of Nations
Divisions: Faculty of Law > 74201-Law (S1)
Depositing User: Mrs Zahratun Fadhilah
Date Deposited: 12 Jul 2019 04:16
Last Modified: 19 Jul 2019 03:53
URI: http://repository.unsri.ac.id/id/eprint/191

Actions (login required)

View Item View Item